Global Next Generation Bio-therapeutics Market, By Therapeutic Application (Oncology Next-Generation Antibody Therapeutics, Autoimmune/Inflammatory Next-Generation Antibody Therapeutics), Technology (Antibody-Drug Conjugates (ADCs), Bispecific Antibodies Market, Fc-engineered Antibodies and Others), Drugs (Brentuximab Vedotin, Trastuzumab and Others), End- Users (Hospitals, Homecare, Specialty Clinics, Others) and  Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.